Wellbeing Digital Sciences Reports Financial Results for the Second Fiscal Quarter of 2022
March 18, 2022 07:00 ET
|
Wellbeing Digital Sciences Inc.
VANCOUVER, British Columbia, March 18, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare...
Wellbeing Digital Sciences Appoints Najla Guthrie as Chief Executive Officer
March 07, 2022 03:00 ET
|
Wellbeing Digital Sciences Inc.
VANCOUVER, British Columbia, March 07, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare...
Wellbeing Digital Sciences Subsidiary IRP Health Receives Approval From Veterans Affairs Canada for Reactivation Program
March 03, 2022 03:00 ET
|
Wellbeing Digital Sciences Inc.
VANCOUVER, British Columbia, March 03, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: MY0), an evidence-based healthcare...
Wellbeing Digital Sciences Delivers its First IV Ketamine Treatment Under the Inpatient KITE Program
February 15, 2022 03:00 ET
|
Wellbeing Digital Sciences Inc.
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare...
Wellbeing Digital Sciences Reveals Recent Achievements by Its KGK Science Subsidiary
February 02, 2022 03:00 ET
|
Wellbeing Digital Sciences Inc.
VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare...
Wellbeing Digital Sciences’ Subsidiary KGK Science Forms Tactical Partnership with Nova Mentis
January 27, 2022 03:00 ET
|
Wellbeing Digital Sciences Inc.
VANCOUVER, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare...
Ketamine One Changes Name to Wellbeing Digital Sciences
January 24, 2022 03:00 ET
|
Wellbeing Digital Sciences Inc.
VANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare...
Ketamine One Becomes Exclusive Ketamine Treatment Provider to Victoria Wellness
January 17, 2022 03:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
Ketamine One Begins Trading on the OTCQB Marketplace on January 12, 2022
January 12, 2022 03:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTCQB: KONEF) (Frankfurt: MY0), a company focused on...
Ketamine One Subsidiary KGK Science Becomes the First Founding Sponsor of the “Psychedelic Science 2023” Event
January 10, 2022 03:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Jan. 10, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...